Inventor
WILLIAMS JODI T
CH15 patents
⚠️ This page may combine multiple inventors who share the name “WILLIAMS JODI T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IDORSIA PHARMACEUTICALS LTD
6 patentsUS12344597B2Jul 1, 2025
Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their use in the treatment of fibrosis
IDORSIA PHARMACEUTICALS LTD2 citations74
US10329287B2Jun 25, 2019
Benzimidazole-proline derivatives
IDORSIA PHARMACEUTICALS LTD3 citations72
US10023560B2Jul 17, 2018
Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
IDORSIA PHARMACEUTICALS LTD3 citations72
US9914720B2Mar 13, 2018
Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists
IDORSIA PHARMACEUTICALS LTD3 citations72
US9790208B2Oct 17, 2017
Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist
IDORSIA PHARMACEUTICALS LTD4 citations72
US9914721B2Mar 13, 2018
Use of benzimidazole-proline derivatives
IDORSIA PHARMACEUTICALS LTD4 citations71
ACTELION PHARMACEUTICALS LTD
3 patentsUS9493446B2Nov 15, 2016
Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives
ACTELION PHARMACEUTICALS LTD6 citations73
US9211279B2Dec 15, 2015
Proline sulfonamide derivatives as orexin receptor antagonists
ACTELION PHARMACEUTICALS LTD3 citations62
US9403813B2Aug 2, 2016
Azetidine amide derivatives as orexin receptor antagonists
ACTELION PHARMACEUTICALS LTD1 citations52